Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo

Experimental Neurology

Volumn 149, Issue 1, 1998, Pages 183-192

  Hagg, Theo ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Axotomy; Brain derived neurotrophic factor; Neuronal death; Neurotrophic factor; Neurotrophin 4 5; Neurotrophin 3; Neurotrophin 4; Nigrostriatal; Parkinson; Substantia nigra

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; TYROSINE 3 MONOOXYGENASE;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; ENZYME SYNTHESIS; FEMALE; NERVE CELL NECROSIS; NERVE FIBER TRANSECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0031888498     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6684     Document Type: Article

References (44)

1. Alexi T., Hefti F. Neurotrophin-4/5 selectively protects nigral calbindin-containing neurons in rats with medial forebrain bundle transections. Neuroscience. 72:1996;911-921.
2. Altar C. A., Boylan C. B., Fritsche M., Jackson C., Hyman C., Lindsay R. M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp. Neurol. 130:1994;31-40.
3. Altar C. A., Boylan C. B., Fritsche M., Jones B. E., Jackson C., Wiegand S. J., Lindsay R. M., Hyman C. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J. Neurochem. 63:1994;1021-1032.
4. Altar C. A., Boylan C. B., Jackson C., Hershenson S., Miller J., Wiegand S. J., Lindsay R. M., Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA. 89:1992;11347-11351.
5. 125125125. Eur. J. Neurosci. 6:1994;1389-1405.
6. Anderson K. D., Alderson R. F., Altar C. A., DiStephano P. J., Corcoran T. L., Lindsay R. M., Wiegand S. J. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J. Comp. Neurol. 357:1995;296-317.
7. Beck K. D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R. A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
8. Bowenkamp K. E., Hoffman A. F., Gerhardt G. A., Henry M. A., Biddle P. T., Hoffer B. J., Granholm A. C. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:1995;479-489.
9. Frim D. M., Uhler T. A., Galpern W. R., Beal M. F., Breakefield X. O., Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc. Natl. Acad. Sci. USA. 91:1994;5104-5108.
10. Grafstein B., McQuarrie I. G. Role of the nerve cell body in axonal regeneration. Neuronal Plasticity. 1978;Raven Press, New York. p. 155-195.
11. Hagg T., Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. Natl. Acad. Sci. USA. 90:1993;6315-6319.
12. Hagg T., Quon D., Higaki J., Varon S. Ciliary neurotrophic factor prevents neuronal degeneration and promotes low affinity NGF receptor expression in the adult rat CNS. Neuron. 8:1992;145-158.
13. Hofer M., Pagliusi S. R., Hohn A., Leibrock J., Barde Y. A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:1990;2459-2464.
14. Hökfelt T., Mårtensson R., Björklund A., Kleinau S., Goldstein M. Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. Björklund A., Hökfelt T. Handbook of Chemical Neuroanatomy. 1984;Elsevier, Amsterdam.
15. Holtzman D. M., Kilbridge J., Li Y., Cunningham E. Jr., Lenn N. J., Clary D. O., Reichardt L. F., Mobley W. C. TrkA expression in the CNS: Evidence for the existence of several novel NGF-responsive CNS neurons. J. Neurosci. 15:1995;1567-1576.
16. Honig M. G., Hume R. I. DiI and diO: Versatile fluorescent dyes for neuronal labelling and pathway tracing. Trends Neurosci. 12:1989;333-335.
17. Hyman C., Juhasz M., Jackson C., Wright P., Ip N. Y., Lindsay R. M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
18. Hynes M. A., Poulsen K., Armanini M., Berkemeier L., Phillips H., Rosenthal A. Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J. Neurosci. Res. 37:1994;144-154.
19. Kearns C. M., Gash D. M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
20. Knüsel B., Beck K. D., Winslow J. W., Rosenthal A., Burton L. E., Widmer H. R., Nikolics K., Hefti F. Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12:1992;4391-4402.
21. Lapchak P. A., Beck K. D., Araujo D. M., Irwin I., Langston J. W., Hefti F. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience. 53:1993;639-650.
22. Levivier M., Przedborski S., Bencsics C., Kang U. J. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15:1995;7810-7820.
23. Lindholm D., da-Penha-Berzaghi M., Cooper J., Thoenen H., Castren E. Brain-derived neurotrophic factor and neurotrophin-4 increase neurotrophin-3 expression in the rat hippocampus. Int. J. Dev. Neurosci. 12:1994;745-751.
24. Lu X., Hagg T. Glial cell line-derived neurotrophic factor (GDNF) prevents death, but not reductions in tyrosine hydroxylase, of injured substantia nigra neurons in adult rats. J. Comp. Neurol. 388:1997;484-494.
25. Maisonpierre P. C., Belluscio L., Squinto S., Ip N. Y., Furth M. E., Lindsay R. M., Yancopoulos G. D. Neurotrophin-3: A neurotrophic factor related to NGF and BDNF. Science. 247:1990;1446-1451.
26. Martin-Iverson M. T., Todd K. G., Altar C. A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine. J. Neurosci. 14:1994;1262-1270.
27. McAllister A. K., Katz L. C., Lo D. C. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron. 18:1997;767-778.
28. Merlio J. P., Ernfors P., Jaber M., Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience. 51:1992;513-532.
29. Mufson E. J., Kroin J. S., Sobreviela T., Burke M. A., Kordower J. H., Penn R. D., Miller J. A. Intrastriatal infusions of brain-derived neurotrophic factor: Retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat. Exp. Neurol. 129:1994;15-26.
30. Okazawa H., Murata M., Watanabe M., Kamei M., Kanazawa I. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Lett. 313:1992;138-142.
31. Seroogy K. B., Lundgren K. H., Tran T. M., Guthrie K. M., Isackson P. J., Gall C. M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342:1994;321-334.
32. Shen R. Y., Altar C. A., Chiodo L. A. Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo. Proc. Natl. Acad. Sci. USA. 91:1994;8920-8924.
33. Shults C. W., Matthews R. T., Altar C. A., Hill L. R., Langlais P. J. A single intramesencephalic injection of brain-derived neurotrophic factor induces persistent rotational asymmetry in rats. Exp. Neurol. 125:1994;183-194.
34. Sobreviela T., Clary D. O., Reichardt L. F., Brandabur M. M., Kordower J. H., Mufson E. J. TrkA-immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350:1994;587-611.
35. Tetzlaff W., Kobayashi N. R., Giehl K. M., Tsui B. J., Cassar S. L., Bedard A. M. Response of rubrospinal and corticospinal neurons to injury and neurotrophins. Prog. Brain Res. 103:1994;271-286.
36. Tomac A., Lindqvist E., Lin L. F., Ogren S. O., Young D., Hoffer B. J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
37. Unsicker K. Growth factors in Parkinson's disease. Prog. Growth Factor Res. 5:1994;73-87.
38. Vahlsing H. L., Hagg T., Spencer M., Conner J. M., Manthorpe M., Varon S. Dose-dependent responses to nerve growth factor by adult rat cholinergic medial septum and neostriatum neurons. Brain Res. 552:1991;320-329.
39. Vejsada R., Sagot Y., Kato A. C. BDNF-mediated rescue of axotomized motor neurones decreases with increasing dose. NeuroReport. 5:1994;1889-1892.
40. Vidal S. M., Villegas P. M., Bray G. M., Aguayo A. J. Persistent retrograde labeling of adult rat retinal ganglion cells with the carbocyanine dye dil. Exp. Neurol. 102:1988;92-101.
41. 125. Soc. Neurosci. Abstr. 17:1991;1121.
42. Williams L. R., Inouye G., Cummins V., Pelleymounter M. A. Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J. Pharmacol. Exp. Therapeut. 277:1996;1140-1151.
43. Yan Q., Matheson C., Sun J., Radeke M. J., Feinstein S. C., Miller J. A. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp. Neurol. 127:1994;23-36.
44. Yan Q., Radeke M. J., Matheson C. R., Talvenheimo J., Welcher A., Feinstein S. C. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378:1997;135-157.